WINDTREE THERAPEUTICS INC /DE/·3

Dec 31, 4:34 PM ET

KPCB China Holdings II, Ltd. 3

3 · WINDTREE THERAPEUTICS INC /DE/ · Filed Dec 31, 2018

Insider Transaction Report

Form 3
Period: 2018-12-21
Holdings
  • Common Stock

    4,336,790
Footnotes (1)
  • [F1]The securities of the Issuer reported in this Form 3 are directly held by Ivy Blue Holdings Limited. KPCB China Fund II, L.P. is the 100% owner of Ivy Blue Holdings Limited. KPCB China Associates II, L.P. is the general partner of KPCB China Fund II, L.P. KPCB China Holdings II, Ltd. is the general partner of KPCB China Associates II, L.P. The directors of KPCB China Holdings II, Ltd. are Brook Byers, Wen Hsieh, James Huang and Theodore Schlein. By virtue of these relationships, Brook Byers, Wen Hsieh, James Huang and Theodore Schlein may be deemed to indirectly beneficially own the securities held by Ivy Blue Holdings Limited, however each disclaims beneficial ownership of such securities, except to the extent of his pecuniary interest therein.

Documents

1 file
  • 3
    rdgdoc.xmlPrimary

    FORM 3